Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Modeling in Therapy01:26

Modeling in Therapy

145
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
145
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

408
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
408
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

153
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
153

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

Journal of the American Chemical Society·2026
Same author

Physiologically Based Pharmacokinetic Model to Predict Drug-Drug Interactions With the Antibody-Drug Conjugate Trastuzumab Deruxtecan.

CPT: pharmacometrics & systems pharmacology·2026
Same author

How can we overcome the pharmacokinetic challenges posed when conducting complex DDI studies?

Expert opinion on drug metabolism & toxicology·2026
Same author

Population Pharmacokinetic Modeling and Exposure-Response Analyses of Nemtabrutinib in Patients With Hematologic Malignancies.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Optimisation before Crohn's surgery using Exclusive enteral Nutrition (OCEaN): A randomised controlled trial to determine whether preoperative exclusive enteral nutrition is more clinically and cost effective compared with standard care in patients undergoing surgery for Crohn's disease.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2026
Same author

Evaluation of the cytochrome P450-mediated drug interaction profile of olorofim.

Antimicrobial agents and chemotherapy·2026

Related Experiment Video

Updated: Sep 8, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity

Ananth Kadambi1, Elke H J Krekels2, Antal Martinecz3

  • 1Certara USA, Radnor, Pennsylvania, USA.

Clinical and Translational Science
|June 17, 2025
PubMed
Summary
This summary is machine-generated.

Clinical trial diversity is crucial for real-world patient safety. Modeling and simulation (M&S) and real-world evidence (RWE) can optimize diversity planning and improve drug development outcomes.

More Related Videos

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.8K
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

1.7K

Related Experiment Videos

Last Updated: Sep 8, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

12.0K
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.8K
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

1.7K

Area of Science:

  • Drug Development
  • Clinical Trials
  • Health Equity

Background:

  • Clinical trials often lack diverse patient representation, leading to post-approval safety issues.
  • Regulatory bodies emphasize the need for diverse populations in clinical trials for real-world effectiveness.
  • Current trial diversity planning methods require enhancement to meet regulatory expectations.

Purpose of the Study:

  • To explore the strategic value of modeling and simulation (M&S) and real-world evidence (RWE) in clinical trial diversity planning.
  • To identify unmet needs and highlight prior thought leadership in utilizing M&S and RWE for diversity.
  • To provide insights into diversity planning across the drug development lifecycle.

Main Methods:

  • Review of existing literature and case examples on M&S and RWE in trial diversity.
  • Analysis of regulatory guidance concerning clinical trial diversity.
  • Synthesis of strategic approaches for integrating M&S and RWE into diversity plans.

Main Results:

  • M&S and RWE offer powerful tools to optimize clinical trial diversity planning.
  • These approaches can enhance the representativeness of trial participants beyond traditional epidemiological data.
  • Early integration of M&S and RWE can mitigate post-approval risks and improve drug efficacy.

Conclusions:

  • M&S and RWE are essential for developing robust and regulatory-acceptable clinical trial diversity plans.
  • Strategic implementation of these methods can improve patient safety and treatment outcomes.
  • Further research and application of M&S and RWE are needed to fully realize their potential in trial diversity.